PMAM
CGON icon

Picton Mahoney Asset Management’s CG Oncology CGON Stock Holding History

Picton Mahoney Asset Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.56M Buy
67,404
+64,554
+2,265% +$3.66M 0.03% 379
2025
Q4 		$118K Buy
+2,850
New +$118K ﹤0.01% 853

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Picton Mahoney Asset Management's CGON Position: Q1 2026 in Review

Picton Mahoney Asset Management increased its CG Oncology (CGON) stake by 2,265% in Q1 2026, buying an estimated $3.66M and bringing the position to 67,404 shares worth $4.56M. The position accounts for 0.03% of the portfolio, ranked #379.

Picton Mahoney Asset Management first reported a position in CGON in Q4 2025 and has held it in 2 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Picton Mahoney Asset Management held 67,404 shares of CG Oncology worth $4.56M as of Q1 2026.
  • Picton Mahoney Asset Management bought 64,554 CG Oncology shares in Q1 2026, an estimated $3.66M.
  • CG Oncology made up 0.03% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #379 holding.
  • Picton Mahoney Asset Management first reported a position in CG Oncology in Q4 2025 and has held it in 2 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.